A total of 264 bacterial strains tentatively or definitely classified as Vibrio anguillarum were examined. The strains were isolated from diseased or healthy Norwegian fish after routine autopsy. With the exception of five isolates from wild saithe (Pollachius virens), the strains originated from nine different species of farmed fish. The bacteria were subjected to morphological, physiological, and biochemical studies, numerical taxonomical analyses, serotyping by slide agglutination and enzyme-linked immunosorbent assay, DNA-plasmid profiling, and in vitro antimicrobial drug susceptibility testing. The results of the microbiological studies were correlated to anamnestic information. The bacterial strains were identified as V. anguillarum serovar 01 (n = 132), serovar 02 (n = 89), serovar 04 (n = 2), serovar 08 (n = 1), and not typeable (n = 1) as well as Vibrio spkndidus biovar I (n = 36) and biovar II (n = 1), Vibrio tubiashii (n = 1), and Vibrio fischerii (n = 1). V. anguillarum serovar 01 or 02 was isolated in 176 out of 179 cases of clinical vibriosis in Atlantic salmon (Salmo salar). V. anguillarum serovar 01 was the only serovar isolated from salmonid fish species other than Atlantic salmon, while V. anguillarum serovar 02 was isolated from all marine fish suffering from vibriosis. A 48-Mda plasmid was isolated from all V. anguillarum serovar 01 isolates examined. Serovar 02 isolates did not harbor any plasmids. Resistance against commonly used antibiotic compounds was not demonstrated among V. anguillarum isolates. Neither V. splendidus biovar I nor other V. anguillarum-related species appeared to be of clinical importance among salmonid fish. However, such bacteria were isolated from diseased turbot (Scopthalmus maximus) and sea bass (Dicentrarchus labrax). The precise role of these bacteria as fish pathogens has to be elucidated. Cell and culture morphology, cell motility, hemolysis patterns, and especially alginate-degrading ability were found to be suitable characteristics for the differentiation of V. splendidus biovar I within the arginine decarboxylase-positive group of Vibrio species. Luminescence could not be demonstrated among V. splendidus isolates.
Vibriosis due to Vibrio anguillarum is one of the most important bacterial infections in fish throughout the world (1, 19) . The disease has great importance, particularly for marine fish farming (4, 15, 55) . Infections have been reported also among farmed bivalve mollusks and crustaceans (11, 12) . V. anguillarum and closely related bacterial species are commonly found in estuarine and coastal marine habitats and can readily be isolated from different environmental sources (31-34, 52, 65, 67) . These bacteria constitute part of the normal microflora of healthy marine fish (34, 41, 45) .
On the basis of biochemical and serological differences, two distinct biotypes of V. anguillarum were described (6, 8, 19) . Biotype 2 was later differentiated as a new species, Vibrio ordalii (54) . A total of 10 different 0 serovars (01 to 010) and additional 0 subgroups and K serotypes have been described among V. anguillarum strains (38, (46) (47) (48) (49) (50) 58) . V. anguillarum 01 and 02 are the most common serovars associated with vibriosis in farmed and feral fish worldwide (57, 58, 63, 64) . Environmental strains of V. angutillaruim usually belong to 0 serovars 03 to 010 or are not typeable (34, 58) .
Other Vibrio species such as V. tubiashii (22) , V. splendidus, V. pelagius (9) , and so-called V. angiillarum-like bacteria or unidentified V. anguillarum-related (VAR) species (13, 31, 32) , commonly considered environmental strains without pathogenic importance, have recently been * Corresponding author.
associated with disease in marine fish and shellfish (21, 28, 30, 37, 37a, 63) . In Norway, V. anguillarum was isolated for the first time in 1964 from diseased farmed rainbow trout (27) . Since then, vibriosis has been a significant problem in Norwegian aquaculture (16, 17, 24, 25, 43, 68) . In general, vaccination is an effective prophylactic measure to control vibriosis (19, 55) , and it was introduced in Norway in 1977 (23) . Vibriosis vaccines employed domestically contain antigen preparations of V. anguillarum serovars 01 and 02. Despite an intensive vaccination campaign, some farms do not vaccinate and vibriosis is still a common diagnosis. Moreover, some VAR species have been isolated from vaccinated fish.
The aim of the present study was to obtain comprehensive information on vibriosis in Norway by characterization of isolates of V. anguillarum and closely related bacterial species from clinical cases. It was of particular interest to evaluate whether other bacterial strains should be included in the vibriosis vaccines used. A further purpose was to establish a taxonomic relationship between V. anguillarum and VAR species.
MATERIALS AND METHODS
Bacterial strains. A total of 264 bacterial strains, provisionally identified as V. anguillarum, were included in the study. Of these, 198 sea trout (Salno trutta) (n = 4), and arctic char (Salvelinasl alpinius) (n = 3). Altogether, 17 strains from marine fish were included in the study: turbot (Scopthlalhus n(aximiiis) (n = 7), saithe (Pollachius 'irens) (n = 5), sea bass (Di(entrtarchlus labrax) (n = 3), cod (Gadius morhimia) (n = 1). and sole (Solea solea) (n = 1). One strain was isolated from a catadromous fish species, eel (Anguil/la atngiilal) (n = 1). Apart from the five isolates from wild saithe, all strains originated from farmed fish. The origins of the strains are given in Tables 1 and 2 Arginine (M0ller) culture from the pronephros of diseased fish from epizootics and/or from individuals exhibiting pathological findings characteristic of hemorrhagic septicemia. Bacteria isolated in low numbers from scantily growing mixed cultures from the kidneys, integument, or mucosal surfaces from healthy individuals investigated as part of a health monitoring program or isolates from diseased or dead fish with a different main diagnosis were designated casual isolates. Plasmid screening. DNA-plasmid patterns were determined in 60 strains: 10 V. anguillarum 01 strains, 9 V. anguillarum 02 strains, and all 41 VAR strains (2 of which were later designated V. anguillarum serovars 02a and 08). All selected strains were isolated in 1987 and 1988 and originated from five different coastal counties. The V. anguillarum serovar 01 strains were isolated from diseased Atlantic salmon (n = 7), rainbow trout (n = 2), and arctic char (n = 1). The serovar 02 isolates were collected from diseased Atlantic salmon (n = 7) and wild saithe (n = 2).
The alkaline lysis method described by Maniatis et al. (39) was employed, with minor modifications. Bacteria were grown in 5 ml of brain heart infusion broth (Difco) containing 2% NaCl at 22°C for 48 h on a shaker. Plasmid-DNA electrophoresis was run on a vertical apparatus with a 1% agarose gel and Tris-borate-EDTA buffer. Plasmids from Escherichia coli V517, PDK9, Sa, and Rl were used as size and 08, were not included in this part of the study. The antimicrobial compounds tested were enrofloxacin, flumequine, oxolinic acid, nitrofurazolidone, oxytetracycline, and trimethoprim-sulfadiazine. MICs were determined by a drug microdilution method as described previously (40) .
RESULTS
Cell and culture characteristics, biochemical tests, and 0/129 resistance. All 264 strains showed identical key phenotypical features, i.e., motile, oxydase-and catalase-positive, gram-negative straight and curved rods which degraded D-glucose fermentatively without gas production. All grew in 1% peptone broth containing 6% NaCl and showed, with one exception, a positive L-arginine dihydrolase-decarboxylase reaction and negative reactions for L-lysine and L-ornithine decarboxylation. All isolates reduced nitrate to nitrite and were sensitive to the vibriostatic agent 0/129.
Regarding 0/129 susceptibility, inconclusive results were initially obtained for the majority of VAR strains. With blood agar or Mueller-Hinton agar containing NaCl and MgCl2, narrow or no inhibition zones were demonstrated. With lysed horse blood agar, comparatively distinct and stable inhibition zones could be observed.
Significant differences between two main groups of bacteria were observed concerning cell and culture morphology, motility patterns, and agglutination against V. angiuillariin 0 antisera. Bacterial isolates with cell and culture morphology and hemolysis patterns resembling those of V. anguiillarirn (34) and which also agglutinated with V. angutillarium antiserum 01 or 02 were designated V. anguillaruim. These organisms were short, straight or curved rods showing rapid motility. The Table 4 . Six V. angiuillaruim isolated from Atlantic salmon without a vibriosis diagnosis were grouped as serovar 01 (n = 4) and 02a (n = 1), while one casual isolate was not groupable ( Table 2 ).
All V. angiuillaruem isolates, clinical or casual, from other salmonid fish (rainbow trout, brown trout, and arctic char)
were serogrouped as 01 (Table 2) . V. an,£giillariin isolates originating from diseased marine fish were all serotyped as serovar 02 or subserovar 02b with the following fish species distribution: wild saithe (n = 4), farmed coastal cod (n = 1), and farmed turbot (n = 1). Antimicrobial susceptibility. The V. anguillarum serovar 01 and 02 strains were highly susceptible to the antibiotics tested in vitro (Table 6 ). Nitrofurazolidone was slightly less effective than the other antibacterial compounds tested. VAR strains as a group showed particularly high resistance to nitrofurazolidine and, to a lesser degree, also to oxytetracycline, flumequine, and trimethoprim-sulfadiazine.
DISCUSSION
The results of the present study show that serovars 01 and 02 of V. anguillarum are of paramount importance as causative agents of vibriosis among cultured salmonid fish, particularly Atlantic salmon, in Norway. This is in accor- Most V. splendidus strains showed reduced 0/129 sensitivity when tested on blood agar plates or Mueller-Hinton agar plates. This can be explained by spontaneous in vitro development of thymine-and thymidine-dependent 0/129-resistant clones of V. splendidus. In vivo and in vitro development and selection of trimethoprim-resistant bacteria unable to synthesize thymidine are well known (2, 29, 42) . A correlation of resistance between the chemically related drug trimethoprim and the vibriostatic compound 0/129 has been reported by several authors (3, 18, 26, 59 ). Such trimethoprim-and 0/129-cross-resistant mutants are dependent on the exogenous supply of thymine and thymidine for DNA synthesis and growth. The in vitro resistance of V. splendidus to the vibriostatic compound 0/129 was not expressed on lysed horse blood agar. This might be explained by the relatively high content of the thymidase enzyme in this particular medium and the inability of thymidine-dependent bacteria to multiply under these conditions (5, 42) . In order to confirm the findings of the present study that most V. splendidus strains seem actually to be thymidine-dependent 0/129-resistant clones, their growth on defined glucose-supplemented minimal salts agar, with and without thymine, would have to be tested. The apparent in vitro 0/129 resistance among V. splendidus strains as recorded on blood agar, creating substantial initial identification problems, might be regarded as a bacterial species marker and thus a characteristic which could be exploited diagnostically.
Other prominent V. splendidus biovar I phenotypical traits, as revealed by the numerical taxonomical part of the study, are the ability to degrade alginate and the negative reactions regarding luminescence and L-arabinose utilization. The alginate-degrading capacity seems to be an excellent trait to distinguish V. splendidus biovar I from other arginine decarboxylase-positive Vibrio species. None of the V. splendidus biovar I isolates tested showed luminescence. This finding is in contrast to previous reports emphasizing this trait as being bacterial biovar specific (6, 7, 9) . Similar phenomena of luminescent and nonluminescent bacterial clusters or subgroups of Vibrio cholerae, Vibrio harveij, and Vibrio vulnificus have been described previously (44, 51, 65) . The taxonomic conclusion is that luminescence is a property of different aquatic vibrios which may or may not be expressed. A parallel conclusion seems appropriate for the V. splendidus group. The inability to produce acid from L-arabinose might serve as a suitable characteristic to differentiate V. splendidus from specific serotypes of V. anguillarum, especially serovar 01.
In our study, no serological cross-reactions were observed between 0-antigen preparations of V. splendidus strains investigated and V. anguillarum 0 antisera 01, 02, and 03. However, in preliminary agglutination assays with V. splendidus 0-antigen preparations and V. anguillarum antisera other than 01, 02, and 03, cross-reactions could be demonstrated.
In conclusion, V. anguillarum 01 and 02 are by far the most common serovars associated with vibriosis in Norwegian farmed fish. Whereas serovars 01 and 02 both caused vibriosis in Atlantic salmon, serovar 01 was the only serovar causing disease among other salmonid fish. Other serovars of V. anguillarum as well as VAR species were also isolated from Atlantic salmon, but only rarely in association with disease. In marine fish species, vibriosis was caused only by V. anguillarum serovar 02. V. splendidus was associated with disease in these fish species. The antigenic composition of current vibriosis vaccines for salmonid fish in Norway is consequently in accordance with the V. anguillarum serovars causing disease. The data from the present study also give a basis for the selection of bacterial strains for vaccines against vibriosis in marine species.
Concerning the taxonomic relations between V. anguillarum and its related species, V. splendidus biovar I was the most frequent species isolated from clinical specimens in this study. In addition to cell and culture characteristics, the alginate-degrading ability was found to be a good parameter for differentiation of V. splendidus biovar I and V. anguillarum.
